🔗 Share this article

The top legal official in Texas Paxton is suing the manufacturers of Tylenol, claiming the companies hid potential risks that the medication created to pediatric neurological development.

The lawsuit arrives four weeks after Donald Trump promoted an unverified association between taking acetaminophen - referred to as acetaminophen - throughout gestation and autism in children.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the drug, the only pain reliever suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a declaration, he claimed they "misled consumers by making money from discomfort and promoting medication regardless of the risks."

Kenvue says there is insufficient reliable data linking acetaminophen to autism spectrum disorder.

"These companies deceived for years, deliberately risking numerous people to line their pockets," Paxton, a Republican, said.

Kenvue said in a statement that it was "deeply concerned by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the well-being of American women and children."

On its website, Kenvue also mentioned it had "consistently assessed the applicable studies and there is no credible data that shows a verified association between taking paracetamol and autism spectrum disorder."

Groups representing doctors and healthcare providers concur.

ACOG has said acetaminophen - the key substance in acetaminophen - is among limited choices for pregnant women to treat discomfort and elevated temperature, which can present major wellness concerns if left untreated.

"In more than two decades of studies on the utilization of acetaminophen in pregnancy, no reliable research has definitively established that the usage of paracetamol in any stage of gestation leads to brain development issues in young ones," the group said.

The lawsuit mentions current declarations from the previous government in arguing the drug is allegedly unsafe.

Recently, Trump generated worry from public health officials when he told expectant mothers to "struggle intensely" not to consume acetaminophen when unwell.

The FDA then issued a notice that doctors should contemplate reducing the use of acetaminophen, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in young ones has remains unverified.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had vowed in April to conduct "extensive scientific investigation" that would determine the origin of autism in a matter of months.

But experts warned that finding a sole reason of autism spectrum disorder - thought by researchers to be the result of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism is a type of enduring cognitive variation and disability that impacts how people experience and relate to the environment, and is recognized using doctors' observations.

In his legal document, Paxton - aligned with the former president who is campaigning for the Senate - claims Kenvue and J&J "intentionally overlooked and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

The case seeks to make the companies "remove any marketing or advertising" that states Tylenol is reliable for women during pregnancy.

This legal action echoes the complaints of a collection of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in recently.

A federal judge rejected the lawsuit, declaring research from the parents' expert witnesses was not conclusive.